Alumni raised $1.45B in 2022 - Download Free Report Now

Impel NeuroPharma (NASDAQ:IMPL)

Pressurized olfactory drug delivery device to bypass the blood brain barrier and deliver greater pharmaceutical concentrations.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Impel NeuroPharma (NASDAQ:IMPL) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Impel NeuroPharma (NASDAQ:IMPL)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

Competing Startups


Companies We Work With